Results 81 to 90 of about 77,870 (215)

Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections.

Journal of Cystic Fibrosis, 2019
BACKGROUND Nontuberculous mycobacteria are recognized as a concern for cystic fibrosis (CF) patients due to increasing disease prevalence and the potential for detrimental effects on pulmonary function and mortality.
B. Banaschewski, D. Verma, Lian J. Pennings, M. Zimmerman, Qihua Ye, Jake Gadawa, V. Dartois, D. Ordway, J. van Ingen, S. Ufer, K. Stapleton, T. Hofmann   +11 more
semanticscholar   +1 more source

Balancing Building Water Conservation and Microbial Water Quality

Water Resources Research, Volume 62, Issue 5, May 2026.
Abstract Flow restrictors are widely used to improve water efficiency by limiting flow rates in faucets and showerheads. While these devices contribute to significant reductions in water consumption and associated energy costs, they may also pose unintended risks to microbial water quality. In healthcare and other high‐risk settings, reduced flow rates
Claire Hayward, Sarah‐Jane Haig, Jimmy Walker, Cathy Whapham, Harriet Whiley   +4 more
wiley   +1 more source

Gaining insights into MmpL3: combining structural and computational approaches to unlock transport and inhibitor‐binding mechanisms

Acta Crystallographica Section D, Volume 82, Issue 5, Page 550-570, May 2026.
This study investigates the mycobacterial membrane protein MmpL3, a key target for new antituberculosis drugs, by combining high‐resolution crystallography and computational simulations. It reveals how the inhibitor UPAR‐1109 binds to MmpL3, providing detailed insights into the function and flexibility of the protein and supporting the rational design ...
Satoshi Murakami, Domenico Marson, Eiki Yamashita, Bruno Broshka, Ui Okada, Maho Aoki, Giannamaria Annunziato, Erik Laurini, Emanuele Carosati, Marco Pieroni   +9 more
wiley   +1 more source

Large-Restriction-Fragment Polymorphism Analysis of Mycobacterium chelonae and Mycobacterium terrae Isolates [PDF]

, 2003
Mycobacterium chelonae and Mycobacterium terrae were reported to be frequently present in the environment of the Mycobacterium bovis BCG trial area in south India. Six isolates of M. chelonae and four isolates of M.
Daisy Vanitha, J, Dharmalingam, K, Paramasivan, C N, Venkatasubramani, R   +3 more
core   +2 more sources

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

Advanced Healthcare Materials, Volume 15, Issue 14, 10 April 2026.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, Aline Martins dos Santos, Jonatas Lobato Duarte, Letícia Oliveira Catarin Nunes, Túlio Custódio Reis, Lara Cerazi Salvador, Norival Alves Santos‐Filho, Rafael Miguel Sábio, Hélder A. Santos, Fernando Rogério Pavan   +11 more
wiley   +1 more source

First report of occurrence of Mycobacterium tuberculosis and Non-tuberculous mycobacteria in a heterozygous carrier of chronic granulomatous patient

International Journal of Mycobacteriology, 2015
Tuberculosis (TB) is one of the most common infections world-wide, and in 2012, an estimated 8.6 million people developed TB and 1.3 million died from the disease (including 320,000 deaths among HIV-positive people).
Dina Soroush, Payam Tabarsi, Hoda Gudarzi, Esmaeil Mortaz, Ian M Adcock, Ali Akbar Velayati   +5 more
doaj  

Mycobacterium abscessus scalp infection after mesotherapy injection

Egyptian Journal of Chest Disease and Tuberculosis
The frequency of nontuberculous mycobacterial skin infections is rising. In immunocompetent patients, they typically occur after local trauma or invasive procedure.
Noha S. Soliman, Sahar M. Khairat, Mai S. Soliman, Amani A. ElKholy   +3 more
doaj   +1 more source

Non-Tuberculous Mycobacteria: Seven-Year Experience of a Tertiary Hospital

Acta Médica Portuguesa, 2019
Introduction: Non-tuberculous mycobacteria are ubiquitous organisms. Precise determination of infection numbers is difficult, since reporting them to public health departments is frequently not mandatory; furthermore, isolating a non-tuberculous ...
Nuno Ferreira Monteiro, Susana Peres, Kamal Mansinho   +2 more
doaj   +1 more source

Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010–2016

Emerging Infectious Diseases, 2019
We investigated a cluster of Mycobacterium fortuitum and M. goodii prosthetic joint surgical site infections occurring during 2010–2014. Cases were defined as culture-positive nontuberculous mycobacteria surgical site infections that had occurred within ...
G. Buser, M. Laidler, P. M. Cassidy, H. Moulton-Meissner, Z. Beldavs, P. Cieslak   +5 more
semanticscholar   +1 more source

Serial and Parallel Testing Strategies for Johne's Disease: Effects on Milk Production Traits and Milk Income on New Zealand Dairy Cattle

New Zealand Journal of Agricultural Research, Volume 69, Issue 2, April 2026.
The suboptimal accuracy of current diagnostic tests necessitates alternative testing strategies to improve the detection of Johne's disease. We studied parallel and serial testing strategies to quantify the association between milk production and Johne's disease status. For this, two commercial Johne's disease Enzyme‐Linked Immunosorbent Assay, ELISAs,
Venkatesh K. M., Nicolas Lopez‐Villalobos, Sandeep K. Gupta, Garry B. Udy, Richard Laven, Venkata Sayoji Rao Dukkipati   +5 more
wiley   +1 more source